ESR1 and breast cancer: In the molecular classification of breast cancer, tumors which lack ER and PR and overexpress MembErbB-2 (MembErbB-2+/ER-PR-) (Table 7) have been included in the ErbB-2-positive molecular subtype, associated with poor outcome [23-25].